Clinical Trial Update: EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial ENRICH-AF evaluating edoxaban for intracranial hemorrhage survivors with atrial fibrillation; the study is currently active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Intracranial Hemorrhage

Drugs mentioned

• Savaysa (edoxaban)

Snippet

Sponsor: Population Health Research Institute | Conditions: Intracranial Hemorrhages, Atrial Fibrillation | Phase 4 | Status: ACTIVE_NOT_RECRUITING